Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • IL Receptor
    (2)
  • Integrin
    (2)
  • PD-1/PD-L1
    (2)
  • TNF
    (2)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Immunology/Inflammation related
    (1)
  • Interleukin
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

olizumab

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    17
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    17
    TargetMol | Inhibitory_Antibodies
Omalizumab
T9926242138-07-4
Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE)
  • Inquiry Price
Size
QTY
Atezolizumab
T99021380723-44-3
Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1 and blocks the interaction of PD-L1 with PD-1. Atezolizumab has antitumor activity and promotes T-cells to attack tumor cells.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Pembrolizumab
Pembrolizumab(anti-PD-1)
T99081374853-91-4
Pembrolizumab (MK-3475) is a humanized monoclonal antibody inhibiting the PD-1 receptor and the first in the class of agents called the HER2 dimerization inhibitors that impairs the ability of HER2 to bind to other members of the HER family.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Nemolizumab
CIM331
T767241476039-58-3
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
  • Inquiry Price
Size
QTY
Itolizumab
EQ-001
T767811116433-11-4
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a recombinant anti-CD6 monoclonal antibody that targets the extracellular SRCR distal domain 1 of CD6, thereby slowing T cell proliferation and inhibiting pro-inflammatory cytokine production. Itolizumab can be used to study conditions such as psoriasis, rheumatoid arthritis (RA), and COVID-19 disease.
  • Inquiry Price
Size
QTY
Fontolizumab
T76808326859-36-3
Fontolizumab (HuZAF) is a humanized monoclonal antibody targeting IFN-gamma, functioning as an immunosuppressive agent and utilized in the study of Crohn's disease [1].
  • Inquiry Price
2-4 weeks
Size
QTY
Apolizumab
T76909267227-08-7
Apolizumab (Hu1D10), a humanized monoclonal antibody targeting the Human leukocyte antigen-DR beta-chain, has been shown to induce apoptosis in chronic lymphocytic leukemia (CLL) cells in vitro [1] [2].
  • Inquiry Price
Size
QTY
Certolizumab pegol
PHA-738144, PHA738144, Certolizumab, CDP870, CDP8 70
T76963428863-50-7
Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-α monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
  • Inquiry Price
Size
QTY
Letolizumab
BMS-986004, BMS986004, BMS2h-572-633-CT-L2
T770611450981-87-9
Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.1 Letolizumab does not induce platelet activation in vitro and does not affect coagulation factors or platelet counts function after repeated dosing in non-human primates.
  • Inquiry Price
Size
QTY
Etrolizumab
rhuMAb Beta7, RG7413, RG 7413, PRO145223, PRO 145223
T771541044758-60-2
Etrolizumab (rhuMAb Beta7) is a humanized intestinal-selective anti-β7 integrin monoclonal antibody that selectively blocks the transport and retention of lymphocytes in the intestinal tract for the study of inflammatory bowel disease (IBD).
  • Inquiry Price
Size
QTY
Dapirolizumab
T77363
Dapirolizumab is an anti-CD40 monoclonal antibody used in research on systemic lupus erythematosus (SLE) and other autoimmune diseases.
  • Inquiry Price
Size
QTY
Pascolizumab
SB-240683
T77426331243-22-2
Pascolizumab (SB-240683) is a humanized monoclonal antibody targeting IL-4, exhibiting asthmatic effects and useful for studying allergic rhinitis.
  • Inquiry Price
Size
QTY
Dapirolizumab pegol
CDP 7657
T826111416147-64-2
Dapirolizumab pegol (CDP 7657), a monoclonal antibody of the Fab'-IgG-κ class, targets CD40LG TNFSF5 and is conjugated with a pegol moiety. The antibody was initially cloned from the Norway rat (Rattus norvegicus).
  • Inquiry Price
Size
QTY
Vonlerolizumab
RG 7888, Pogalizumab, MOXR 0916
T9901A-0061638935-72-4
Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases.
  • Inquiry Price
Size
QTY
Certolizumab
Anti-Human TNFA
T9901A-703
Certolizumab is an antibody that helps relieve pain and swelling in arthritis. It works by blocking tumor necrosis factor (TNF). It is being studied for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease.
  • Inquiry Price
7-10 days
Size
QTY
Vedolizumab
T9914943609-66-3
Vedolizumab, a humanized monoclonal antibody, targets the α4β7 integrin for treating Crohn's disease and ulcerative colitis.
  • Inquiry Price
Size
QTY
Mepolizumab
SB 240563
T9962196078-29-2
Mepolizumab (SB 240563) is a humanized monoclonal antibody that neutralizes IL-5, and can be utilized in research on severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale